OpenFlo Urinary Catheter
Urolution Medical, Inc. · Decision date Oct 6, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-10-06 for the OpenFlo Urinary Catheter, submitted by Urolution Medical, Inc. of Maple Grove, Minnesota, under 510(k) number K261141. The application was received on 04/07/2026 and reviewed as a traditional 510(k) by FDA rather than a third party, with no combination product status and no authorized predetermined change control plan. The device falls under product code EZL, regulation 876.5130, in the Gastroenterology/Urology specialty and review panel.
SESE in this record means FDA cleared the device as substantially equivalent to a legally marketed predicate; it is not a PMA approval. The public listing identifies the device classification as a retention-type balloon catheter. The record does not describe the device's components, materials, design changes, indications for use, or the predicate device relied upon, and no clinical or performance data are summarized in the available fields. Those details would reside in the underlying 510(k) submission rather than this database entry.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Oct 6, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261141
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Urolution Medical, Inc.
- Product code
- EZL
- Decision code
- SESE
- Decision date
- Oct 6, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Catheter, Retention Type, Balloon.
- Applicant
- Urolution Medical, Inc.
- Product code
- EZL
- FDA device class
- 2
FDA decision timeline
K261141 received
Application receipt date recorded by FDA.
K261141 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code EZL
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Sentinel Medical Technologies, | 510(k) clearance | Sep 4, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Urolution Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Maple Grove, MN
Sources and methodology
- Original FDA record: K261141
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records